# PGE2/IL-22 Pathway in Various Forms of Eczema

> **NCT04133506** · — · COMPLETED · sponsor: **NHS Lothian** · enrollment: 38 (actual)

## Conditions studied

- Eczema

## Interventions

- **DRUG:** Aspirin 300mg

## Key facts

- **NCT ID:** NCT04133506
- **Lead sponsor:** NHS Lothian
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-04
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04133506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04133506, "PGE2/IL-22 Pathway in Various Forms of Eczema". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04133506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*